Drug distribution in the vitreous humor of the human eye: The effects of aphakia and changes in retinal permeability and vitreous diffusivity

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 5, 1997, Pages 445-459

  Friedrich, Stuart ^a,b   Saville, Bradley ^a   Cheng, Yu Ling ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; FLUORESCEIN; FLUORESCEIN GLUCURONIDE;

APHAKIA; ARTICLE; BLOOD RETINA BARRIER; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; FINITE ELEMENT ANALYSIS; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; RETINA; VITREOUS BODY;

EID: 0031416132     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.445     Document Type: Article

References (27)

1. Lee, V.H.L., Pince, K.J., Frambach, D.A., et al. Drug delivery to the posterior segment. In Retina. Ogden, T.E. and Schachat, A.P., eds. CV Mosby, St. Louis, 1989, p. 483-498.
2. Forster, R.K., Abbott, R.L. and Gelender, H. Management of infectious endophthalmitis. Ophthalmology, 87:313-319, 1980.
3. Pflugfelder, S.C., Hernandez, E., Fliesler, S.J., et al. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch. Ophthalmol., 105:831-837, 1987.
4. Stainer, G.A., Peyman, G.A., Meisels, H., et al. Toxicity of selected antibiotics in vitreous replacement fluid. Ann. Ophthalmol., 9:615-618, 1977.
5. Tabatabay, C.A., D'Amico, D.J., Hanninen, L.A., et al. Experimental drusen formation induced by intravitreal aminoglycoside injection. Arch. Ophthalmol., 105:826-830, 1987.
6. Talamo, J.H., D'Amico, D.J., Hanninen, L.A., et al. The influence of aphakia and vitrectomy on experimental retinal toxicity of aminoglycoside antibiotics. Am. J. Ophthalmol., 100:840-847, 1985.
7. Kattan, H.M., Flynn, H.W., Pflugfelder, S.C., et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology, 98:227-238, 1991.
8. Peyman, G.A. and Schulman, J.A. Intravitreal drug therapy. In Intravitreal Surgery. Anonymous eds. Appleton-Century-Crofts, Norwalk, 1986, p. 407-455.
9. Speaker, M.G. and Menikoff, J.A. Postoperative endophthalmitis: pathogenesis, prophylaxis, and management. Int. Ophthalmol. Clin., 33:51-79, 1993.
10. The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 90:121-125, 1983.
11. Goldberg, M.F. Diseases affecting the inner blood-retinal barrier. In The Blood-Retinal Barriers, Cunha-Vaz, J.G., eds. Plenum Press, New York, 1979, p. 309-363.
12. Frank, R.N. The mechanism of blood-retinal barrier breakdown in diabetes. Arch. Ophthalmol., 103:1303-1304, 1985.
13. Friedrich, S.W., Cheng, Y-L., and Saville, B.A. Finite element modelling of drug distribution in the vitreous humor of the rabbit eye Ann. Biomed. Eng., 25(3):303-315, 1997.
14. Sebag, J., The Vitreous: Structure, Function and Pathobiology, Springer-Verlag, New York, 1989, p. 1.
15. McDonnel, J.H. Ocular embryology and anatomy. In Retina: Basic Science, Inherited Retinal Disease, and Tumors. Ogden, T.E., eds., C.V. Mosby Company, St. Louis, 1989, Volume 1, p. 12.
16. Araie, M. and Maurice, D.M. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp. Eye Res., 52:27-39, 1991.
17. Ogura, Y., Tsukahara, Y., Saito, I. and Kondo, T. Estimation of the permeability of the blood-retinal barrier in normal individuals. Invest. Ophthalmol. Vis. Sci., 26:969-976, 1985.
18. Ohtori, A. and Tojo, K. In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation. Biol. Pharm. Bull., 17:283-290, 1994.
19. Yoshida, A., Ishiko, S., and Kojima, M. Outward permeability of the blood-retinal barrier. Graef. Arch. Clin. Exp. Ophthalmol., 230:78-83, 1992.
20. Yoshida, A., Kojima, M., Ishiko, S., et al. Inward and outward permeability of the blood-retinal barrier. In Ocular fluorophotometry and the future. Cunha-Vaz, J. and Leite, E., eds., Kugler & Ghedini Pub., Amsterdam, 1989, p. 89-97.
21. Sebag, J. Aging of the vitreous. Eye, 1:254-262, 1987.
22. Maurice, D.M. and Mishima, S. Ocular pharmacokinetics. In Pharmacology of the Eye. Vol. 69, Handbook of Experimental Pharmacology. Sears, M.L., ed., Springer-Verlag, New York, 1984, p. 72.
23. Davis, B.K. Diffusion in polymer gel implants. Proc. Nat. Acad. Sci. U. S. A., 71:3120-3123, 1974.
24. Blinkhorst, C. Corneal and retinal complications after cataract extraction. The mechanical aspect of endophthalmodonesis. Ophthalmology, 87:609-617, 1980.
25. Algvere, P.V., Hallnas, K., Dafgard, E., et al. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy. Graef. Arch. Clin. Exp. Ophthalmol., 228:461-466, 1990.
26. Kaiser, R. and Maurice, D.M. The diffusion of fluorescein in the lens. Exp. Eye Res., 3:156-165, 1964.
27. Tsukahara, Y. and Maurice, D.M. Local pressure effects on vitreous kinetics. Exp. Eye Res., 60:563-574, 1995.